Download PDF
Rofo 2015; 187(11): 1011-1015
DOI: 10.1055/s-0035-1553348
Head/Neck
© Georg Thieme Verlag KG Stuttgart · New York

Localized Thyroid Tissue Ablation by High Intensity Focused Ultrasound: Volume Reduction, Effects on Thyroid Function and Immune Response

Lokale Ablation von Schilddrüsengewebe durch hochintensiven fokussierten Ultraschall: Volumenreduktion, Auswirkungen auf die thyroidale Funktion und Immunreaktion
H. Korkusuz
1   German Center for Thermoablation of Thyroid Nodules, University Hospital, Frankfurt am Main, Germany
,
M. Sennert
2   Department of Nuclear Medicine, University Hospital, Frankfurt am Main, Germany
,
N. Fehre
2   Department of Nuclear Medicine, University Hospital, Frankfurt am Main, Germany
,
C. Happel
1   German Center for Thermoablation of Thyroid Nodules, University Hospital, Frankfurt am Main, Germany
,
F. Grünwald
1   German Center for Thermoablation of Thyroid Nodules, University Hospital, Frankfurt am Main, Germany
› Author Affiliations
Further Information

Publication History

22 February 2015

30 May 2015

Publication Date:
22 July 2015 (online)

Also available at
   Permissions and Reprints

Abstract

Purpose: The aim of this study was to assess the effectiveness of high intensity focused ultrasound (HIFU) in reducing thyroid nodule volume while preserving thyroid function as measured by immunological response.

Materials and Methods: 12 patients (9 females) whose average age was 56.9 years (37 – 81) were treated with HIFU in an ambulatory setting. All patients had a single benign thyroid nodule treated in one HIFU session. The median nodular outline volume (NOV) was 3.4 ml (range 0.6 – 5.0 ml). The therapeutic ultrasound probe (Echopulse® THC900 888-H) used works with a frequency of 3 MHz, reaching temperatures of 80 – 90° C and a mean output between 87.6 and 192.8 W. To assess possible effects of HIFU on thyroid function, serum levels of triiodothyronine (T3), thyroxine (T4), thyrotropin (TSH), thyroglobulin (hTg) and antibodies against thyroglobulin (TAbs), thyrotropin receptors (TRAbs) and thyroid peroxidase (TPOAbs) were measured at enrollment, 24-hours post-HIFU treatment and at 3-month follow-up.Pre- post thyroglobulin reduction was measured to evaluate the success of ablation and the nodular outline volume (NOV) was evaluated at baseline and the 3-month follow-up to assess effectiveness.

Results: All measured hormone levels were within normal ranges and remained stable (p > 0.05). No clinically meaningful immune reaction was induced (p > 0.05). Thyroglobulin serum levels increased significantly at 24 hours after ablation (p < 0.05) and decreased significantly at the 3-month follow-up (p < 0.05), returning to pre-ablative levels. The median reduction in nodular outline volume (NOV) was 55 % (p < 0.05).

Conclusion: HIFU is a safe and effective alternative for treating benign thyroid nodules, while preserving thyroid function. Further investigations with multiple treatments should be conducted to evaluate whether additional treatments can achieve greater volume reduction.

Key points:

• HIFU is a safe and effective method to treat thyroid nodules.

• HIFU does not interfere with thyroid gland function.

• HIFU does not induce any immune response like Graves’ disease.

Citation Format:

• Korkusuz H, Sennert M, Fehre N et al. Localized Thyroid Tissue Ablation by High Intensity Focused Ultrasound: Volume Reduction, Effects on Thyroid Function and Immune Response. Fortschr Röntgenstr 2015; 187: 1011 – 1015

Zusammenfassung

Ziel: Das Ziel dieser Studie war, die Effektivität von hochintensivem fokussiertem Ultraschall (HIFU) zu beurteilen. Es wurden die Volumenreduktion der Knoten, die Funktion der Schilddrüse und eventuell auftretende Immunreaktionen evaluiert.

Material und Methoden: Zwölf Patienten (neun weiblich, Durchschnittsalter 56,9 Jahre) wurden ambulant mit HIFU an der Schilddrüse behandelt. Alle Patienten hatten einen einzelnen benignen Schilddrüsenknoten, der in jeweils einer Therapiesitzung behandelt wurde. Das mittlere Knotenvolumen (nodular outline volume) betrug 3,4 ml (Bereich 0,6 – 5,0 ml). Die therapeutische Ultraschallsonde (Echopulse® THC900 888-H), die in dieser Studie verwendet wurde, arbeitet mit einer Frequenz von 3 MHz, erreicht eine mittlere Temperatur von 80 – 90 °C und sendet eine mittlere akustische Leistung von 87,6 bis 192,8 Watt aus. Die Serumspiegel von Trijodthyronin (T3), Thyroxin (T4), Thyreotropin (TSH), Thyreoglobulin (hTg) und zusätzlich Antikörper gegen Thyreoglobulin (TAK), Thyreotropin-Rezeptoren (TRAK) und Thyreoperoxidase (TPO) wurden bei der Aufnahme, 24 Stunden nach der Therapie und drei Monate nach der Therapie gemessen. Die prä-post Thyreoglobulin-Reduktion wurde gemessen, um den Erfolg der Ablation einzuschätzen. Außerdem wurde das Knotenvolumen mit der Variable Nodular Outline Volume (NOV) untersucht, um die Effektivität zu bestimmen.

Ergebnisse: Die Hormonspiegel sind stabil geblieben (p < 0,05). Es wurde keine Autoimmunerkrankung, wie etwa eine Autoimmunthyreoditis hervorgerufen (p > 0,05). Die Serumthyreoglobulinspiegel sind 24 Stunden nach der Ablation signifikant angestiegen (p > 0,05). 3 Monate nach der Ablation wiederum sind sie signifikant abgefallen (p < 0,05) und erreichten das prä-ablative Niveau. Das mittlere Knotenvolumen (NOV) konnte um 55 % reduziert werden (p < 0,05).

Schlussfolgerung: HIFU ist eine sichere und effektive Methode, um benigne Schilddrüsenknoten zu behandeln. Die Funktion der Schilddrüse wird nicht beeinträchtigt. Um eine noch größere Volumenreduktion zu erreichen, könnten mehrfache Sitzungen Erfolg versprechen.

Kernaussagen:

• HIFU ist eine sichere und effektive Methode, um benigne Schilddrüsenknoten zu behandeln.

• HIFU beeinträchtigt die Funktion der Schilddrüse nicht.

• HIFU induziert keine ernste Immunreaktion, wie etwa Morbus Basedow.

Key words

high intensity focused ultrasound - thyroid nodule - thermal ablation - thyroid hormones - thyroid function - thyroglobulin
 

  • References

  • 1 Etzel M, Happel C, von Müller F et al. Palpation and elastography of thyroid nodules in comparison. Nuklearmedizin 2013; 52: 97-100
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Reiners C, Schumm-Draeger PM, Geling M et al. Schilddrüsenultraschallscreening (Initiative Papillon). Internist 2003; 44: 412-419
    CrossrefPubMedGoogle Scholar
  • 3 Schicha H, Hellmich M, Lehrmacher W et al. Should all patients with thyroid nodules ≥ 1 cm undergo fine-needle aspiration biopsy?. Nuklearmedizin 2009; 48: 79-83
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Schmid KW, Sheu SY, Görges R et al. Tumoren der Schilddrüse. Pathologe 2003; 24: 357-372
    CrossrefPubMedGoogle Scholar
  • 5 Völzke H, Lüdemann J, Robinsn DM et al. The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid 2003; 13: 803-810
    CrossrefPubMedGoogle Scholar
  • 6 Happel C, Truong PN, Bockisch B et al. Colour-coded duplex-sonography versus scintigraphy. Can scintigraphy be replaced by sonography for diagnosis of functional thyroid autonomy?. Nuklearmedizin 2013; 52: 157-203
    PubMedGoogle Scholar
  • 7 Korkusuz H, Happel C, Heck K et al. Percutaneous thermal microwave ablation of thyroid nodules. Nuklearmedizin 2014; DOI: 10.3413/Nukmed-0631-13-10.
    PubMedGoogle Scholar
  • 8 Jeong WK, Baek JH, Rhim H et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol 2008; 18: 1244-1250
    CrossrefPubMedGoogle Scholar
  • 9 Yue W, Wang S, Wang B et al. Ultrasound guided percutaneous microwave ablation of benign thyroid nodules: Safety and imaging follow-up in 222 patients. Eur J Radiol 2013; 82: e11-e16
    CrossrefPubMedGoogle Scholar
  • 10 Dietlein M, Dressler J, Grünwald F et al. Leitlinie zur Radioiodtherapie (RIT) bei benignen Schilddrüsenerkrankungen (Version 4). Nuklearmedizin 2007; 46: 220-223
    PubMedGoogle Scholar
  • 11 Lin CM, Doyle P, Tsan YT et al. 131I treatment for thyroid cancer and risk of developing primary hyperparathyroidism: a cohort study. Eur J Nucl Med Mol Imaging 2014; 41: 253-259
    CrossrefPubMedGoogle Scholar
  • 12 Martino E, Murtas ML, Loviselli A et al. Percutaneous intranodular ethanol injection for treatment of autonomously functioning thyroid nodules. Surgery 1992; 112: 1161-1165
    PubMedGoogle Scholar
  • 13 Korkusuz H, Happel C, Grünwald F. Ultrasound guided percutaneous microwave ablation of hypofunctional thyroid nodules: evaluation by scintigraphic 99mTc-MIBI imaging. Nuklearmedizin 2013; 52: 205-257
    PubMedGoogle Scholar
  • 14 Na DG, Lee JH, Jung SL. Korean Society of Thyroid Radiology (KSThR); Korean Society of Radiology. et al. Ablation of Benign Thyroid Nodules and Recurrent Thyroid Cancers: Consensus Statement and Recommendations. Korean J Radiol 2012; 13: 117-125
    CrossrefPubMedGoogle Scholar
  • 15 Christou N, Mathonnet M. Complications after total thyroidectomy. J Visc Surg 2013; 150: 249-256
    PubMedGoogle Scholar
  • 16 Ha EJ, Baek JH, Lee JH. The efficacy and complications of radiofrequency ablation of thyroid nodules. Current Opinion in Endocrinology, Diabetes & Obesity 2011; 18: 310-314
    PubMedGoogle Scholar
  • 17 Tarantino L, Francica G, Sordelli I et al. Percutaneous Ethanol Injection of Hyperfunctioning Thyroid Nodules: Long-Term Follow-Up in 125 Patients. Am J Roentgenol 2008; 190: 800-808
    CrossrefPubMedGoogle Scholar
  • 18 Feng B, Liang P, Cheng Z et al. Ultrasound-guided percutaneous microwave ablation of benign thyroid nodules: experimental and clinical studies. Eur J Endocrinol 2012; 166: 1031-1037
    CrossrefPubMedGoogle Scholar
  • 19 Kaiser WA, Pfleiderer SO, Baltzer PA. MRI-guided interventions of the breast. J Magn Reson Imaging 2008; 27: 347-355
    CrossrefPubMedGoogle Scholar
  • 20 Pérez-López FR, Ornat L, Ceausu I et al. EMAS position statement: Management of uterine fibroids. Maturitas 2014; pii: S0378-5122(14)00198-4
    PubMedGoogle Scholar
  • 21 Rewcastle JC. High intensity focused ultrasound for prostate cancer: A review of the scientific foundation, technology and clinical outcomes. Technol Cancer Res Treat 2006; 5: 619-625
    CrossrefPubMedGoogle Scholar
  • 22 Illing RO, Kennedy JE, Wu F et al. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumors in a Western population. Br J Cancer 2005; 93: 890-895
    CrossrefPubMedGoogle Scholar
  • 23 Korkusuz H, Sennert M, Fehre N et al. Local thyroid tissue ablation by high-intensity focused ultrasound: effects on thyroid function and first human feasibility study with hot and cold thyroid nodules. Int J Hyperthermia 2014; 30 : 480-485
    CrossrefPubMedGoogle Scholar
  • 24 Korkusuz H, Fehre N, Sennert M et al. Early assessment of high-intensity focused ultrasound treatment of benign thyroid nodules by scintigraphic means. J Ther Ultrasound 2014; 2: 18
    CrossrefPubMedGoogle Scholar
  • 25 Korkusuz H, Fehre N, Sennert M et al. Volume reduction of benign thyroid nodules 3 months after a single treatment with high-intensity focused ultrasound (HIFU). J Ther Ultrasound 2015; 3: 4
    CrossrefPubMedGoogle Scholar
  • 26 Esnault O, Rouxel A, Le Nestour E et al. Minimally invasive ablation of a toxic thyroid nodule by High-Intensioty Focused Ultrasound. Am J Neuroradiol 2010; 31: 1967-1968
    CrossrefPubMedGoogle Scholar
  • 27 Esnault O, Franc B, Ménégaux F et al. High-intensity focused ultrasound ablation of thyroid nodules: first human feasibility study. Thyroid 2011; 21: 965-973
    CrossrefPubMedGoogle Scholar
  • 28 Esnault O, Franc B et al. Localized ablation of thyroid tissue by high-intensity focused ultrasound: improvement of noninvasive tissue necrosis methods. Thyroid 2009; 19: 1085-1091
    CrossrefPubMedGoogle Scholar
  • 29 R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing: Vienna, Austria; 2013. ISBN 3-900051-07 http://www.R-project.org/
    Google Scholar
  • 30 Bhuyan BK. Kinetics of cell kill by Hyperthermia. Cancer Res 1979; 39: 2277-2284
    PubMedGoogle Scholar
  • 31 Vogl TJ et al. Interventionelle Thermoablation von malignen Lebertumoren und Lebermetastasen: Vergleich von Radiofrequenzablation (RFA), laserinduzierter Thermotherapie (LITT) und Mikrowellenablation (MWA). Hessisches Ärzteblatt 2011; 72: 606-615
    PubMedGoogle Scholar
  • 32 Valcavi R, Riganti F, Bertani A et al. Percutaneous Laser Ablation of Cold Benign Thyroid Nodules: A 3-Year Follow-Up Study in 122 Patients. Thyroid 2010; [cited 2014 Feb 4] 20: 1253-1261
    CrossrefPubMedGoogle Scholar